Imagine facing a post-antibiotic era where previously manageable infections become deadly due to rampant multidrug-resistant bacteria. This emerging threat to global health has pushed scientists to innovate to avert a crisis. The National Institutes of Health (NIH) has awarded $3.96 million to
The discovery of a critical mechanism involving the protein USP39 has opened new avenues for understanding and potentially treating diseases like retinitis pigmentosa and certain cancers. Researchers have revealed that USP39 plays a crucial role in maintaining the stability of spliceosome subunits
In light of potential regulatory relaxations under the Trump administration, South Korean pharmaceutical and biotech companies are eagerly eyeing the opportunities to secure FDA approvals for their innovative drugs. This ambitious pursuit has been catalyzed by the prospect of a more lenient
Benitec Biopharma Inc., headquartered in Hayward, California, has recently released its financial results for the first quarter of fiscal 2025. Alongside this, the company has provided an extensive operational update, highlighting significant clinical progress, financial health, and a detailed
Some studies presents an in-depth analysis of how the density of microorganisms, or microbial load, in the human gut can impact overall health and contribute to various diseases. This relatively new dimension of gut microbiome research, as illustrated by the study conducted by the Bork group at
The development and review timelines for new drugs are critical in addressing the immediate medical needs of patients with serious conditions. In this context, the United States Food and Drug Administration (FDA)’s Fast Track and Accelerated Approval pathways play a pivotal role. These regulatory
